Qinghong Yu

1.1k total citations
34 papers, 845 citations indexed

About

Qinghong Yu is a scholar working on Rheumatology, Hematology and Molecular Biology. According to data from OpenAlex, Qinghong Yu has authored 34 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 9 papers in Hematology and 8 papers in Molecular Biology. Recurrent topics in Qinghong Yu's work include Rheumatoid Arthritis Research and Therapies (6 papers), Systemic Lupus Erythematosus Research (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Qinghong Yu is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Systemic Lupus Erythematosus Research (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Qinghong Yu collaborates with scholars based in China, Australia and United States. Qinghong Yu's co-authors include G.W. Barton, Minghua Zhou, Lecheng Lei, Yuan Qu, Ligang Jie, Jing Wu, Hongyan Du, J. S. Deng, Yingsong Wu and Hongwei Li and has published in prestigious journals such as Blood, Chemosphere and Frontiers in Immunology.

In The Last Decade

Qinghong Yu

33 papers receiving 828 citations

Peers

Countries citing papers authored by Qinghong Yu

Since Specialization

Citations

This map shows the geographic impact of Qinghong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinghong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinghong Yu more than expected).

Fields of papers citing papers by Qinghong Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinghong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinghong Yu. The network helps show where Qinghong Yu may publish in the future.

Co-authorship network of co-authors of Qinghong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Qinghong Yu. A scholar is included among the top collaborators of Qinghong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinghong Yu. Qinghong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Superior outcome from frontline cord blood transfusion combined HLA-full-matched unrelated donor hematopoietic stem cell transplantation for aplastic anemia 2025 ·Blood ·Xinru Jia, (unknown), (unknown), Qi Liu, Ying‐Ying Shen, (unknown), Shan Liu, (unknown), Rui Zheng, (unknown), Wenbin Liu, Qinghong Yu, (unknown), (unknown), (unknown), Baodong Ye, Dijiong Wu	0
2	The FTO-CMPK2 Pathway in Fibroblast-like Synoviocytes Modulates Rheumatoid Arthritis Synovial Inflammation and Cartilage Homeostasis via mtDNA Regulation 2024 ·International Journal of Biological Sciences ·Jin Li, (unknown), Ke Hu, (unknown), Heping Zhang, J. S. Deng, Weizhong Qi, Qinghong Yu	17
3	The immunoregulatory effects of total glucosides of peony in autoimmune diseases 2024 ·Journal of Leukocyte Biology ·(unknown), Na Peng, (unknown), Yuan Qu, Meng Cao, Qinghua Zou, Qinghong Yu, Liwei Lu, Fan Xiao	4
4	Chitin-derived biochar with nitrogen doping to activate persulfate for phenol degradation: Application potential and electron transfer pathway in system 2023 ·Chemosphere ·(unknown), Tao Feng, Si Wu, Shuai Wang, Yi Tan, Qinghong Yu, Ranran Huang, Xinyue Zhang	25
5	Comparison of haploidentical–allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study 2023 ·Annals of Hematology ·Liqiang Wu, Lifang Huang, Hui Yang, Baodong Ye, (unknown), Qinghong Yu, (unknown), Jinsong Jia, Donghua Zhang, (unknown), Guangsheng He, Jianyong Li	1
6	Response to belimumab among patients with refractory lupus nephritis: a real-world observational retrospective multicenter study 2023 ·Clinical Rheumatology ·(unknown), Qian Qiu, Shan Zeng, Hao Li, (unknown), Ligang Jie, Xuejun Hu, (unknown), Dongying Chen, Zhongping Zhan, Liuqin Liang, Qinghong Yu, Hanshi Xu	4
7	Investigational spleen tyrosine kinase (SYK) inhibitors for the treatment of autoimmune diseases 2022 ·Expert Opinion on Investigational Drugs ·Su’an Tang, Qinghong Yu, Changhai Ding	26
8	Bioinformatic identification and validation of autophagy-related genes in rheumatoid arthritis 2022 ·Clinical Rheumatology ·(unknown), (unknown), Jin Li, Yuan Qu, Qinghong Yu	8
9	GeneChip expression profiling identified OLFML2A as a potential therapeutic target in TNBC cells 2022 ·Annals of Translational Medicine ·Xiufei Gao, Zimei Yang, Chuchu Xu, Qinghong Yu, (unknown), (unknown), Chunyu Wu, Mingcang Chen	5
10	Amorphophalli Rhizoma inhibits breast cancer growth, proliferation, migration, and invasion via the PI3K/AKT pathway 2021 ·Journal of Ethnopharmacology ·(unknown), Mingcang Chen, Zimei Yang, Chuchu Xu, Qinghong Yu, (unknown), (unknown), Xiufei Gao	7
11	Can low-dose methotrexate reduce effusion-synovitis and symptoms in patients with mid- to late-stage knee osteoarthritis? Study protocol for a randomised, double-blind, and placebo-controlled trial 2020 ·Trials ·Zhaohua Zhu, Qinghong Yu, Xiaomei Leng, Weiyu Han, Zhanguo Li, Cibo Huang, Jieruo Gu, Yi Zhao, Kang Wang, Li T, Yifang Mei, Jianhua Xu, Zhiyi Zhang, David J. Hunter, Flavia Cicuttini, Xiaofeng Zeng, Changhai Ding	9
12	Tanshinone IIA Suppresses Proliferation and Inflammatory Cytokine Production of Synovial Fibroblasts from Rheumatoid Arthritis Patients Induced by TNF-α and Attenuates the Inflammatory Response in AIA Mice 2020 ·Frontiers in Pharmacology ·Hongyan Du, Yuechun Wang, (unknown), Xiaoming Huang, (unknown), (unknown), Yang Li, Xiaochen Chen, Tiancai Liu, Hongwei Li, Jing Wu, Qinghong Yu, Yingsong Wu, Ligang Jie	50
13	Kirenol inhibits RANKL-induced osteoclastogenesis and prevents ovariectomized-induced osteoporosis via suppressing the Ca2+-NFATc1 and Cav-1 signaling pathways 2020 ·Phytomedicine ·Binhua Zou, (unknown), (unknown), Yanhui Tan, Ligang Jie, Yuan Qu, Qin Yang, (unknown), (unknown), Yan Chen, Qinghong Yu, Xiaojuan Li	34
14	Identification of long non‐coding RNA MVIH as a prognostic marker and therapeutic target in acute myeloid leukemia 2019 ·Journal of Clinical Laboratory Analysis ·(unknown), Qinghong Yu, (unknown)	4
15	A Novel Phytochemical, DIM, Inhibits Proliferation, Migration, Invasion and TNF-α Induced Inflammatory Cytokine Production of Synovial Fibroblasts From Rheumatoid Arthritis Patients by Targeting MAPK and AKT/mTOR Signal Pathway 2019 ·Frontiers in Immunology ·Hongyan Du, Xi Zhang, (unknown), Xiaoming Huang, Hao Chen, Suihai Wang, Jing Wu, (unknown), Wei Zhu, Hongwei Li, Tiancai Liu, Qinghong Yu, Yingsong Wu, Ligang Jie	114
16	Kirenol Inhibits the Function and Inflammation of Fibroblast-like Synoviocytes in Rheumatoid Arthritis in vitro and in vivo 2019 ·Frontiers in Immunology ·Jing Wu, Qiang Li, Jin Li, Yuan Qu, (unknown), Xiaotong Zhu, Hongyan Du, Ligang Jie, Qinghong Yu	41
17	Combined use of Chinese medicine with allogeneic hematopoietic stem cell transplantation for severe aplastic anemia patients 2014 ·Chinese Journal of Integrative Medicine ·Baodong Ye, Xiang Zhang, (unknown), Dan Chen, Yu Zhang, Dijiong Wu, Qinghong Yu, Jianping Shen, (unknown), Yuhong Zhou	8
18	Successful use of rituximab in platelet transfusion refractoriness in a multi-transfused patient with myelodysplastic syndrome 2013 ·Platelets ·Qinghong Yu, (unknown), (unknown), Yuhong Zhou	16
19	Realgar bioleaching solution is a less toxic arsenic agent in suppressing the Ras/MAPK pathway in Caenorhabditis elegans 2013 ·Environmental Toxicology and Pharmacology ·Dongling Liu, Dejuan Zhi, Ting Zhou, Qinghong Yu, (unknown), Yanli Bai, Hongyu Li	17
20	Arsenic Trioxide-Enhanced, Matrine-Induced Apoptosis in Multiple Myeloma Cell Lines 2013 ·Planta Medica ·Qinghong Yu, (unknown), Xiang Zhang, Wenbin Qian, Baodong Ye, Yuhong Zhou	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact